Delivery Order SPE2DE24DA017-SPE2D625F2XY2
- Not listed
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a $2,475 fixed-price delivery order on August 8, 2025, for the Arthrex ACP Double Syringe System. The contract, issued by the Defense Logistics Agency's Medical Supply Chain, carries an ultimate completion date of August 13, 2025, and represents a non-set-aside award. This delivery order falls under the company's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a delivery order from the Defense Logistics Agency's Medical Supply Chain on September 4, 2025, for the Arthrex ACP Double Syringe System. This fixed-price delivery order, valued at $3,300, is scheduled for completion by September 9, 2025, and represents a task order issued under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a $1,650 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on September 3, 2025, for the Arthrex ACP Double Syringe System. This delivery order, with an ultimate completion date of September 8, 2025, represents a task order issued under Arthrex's significant Indefinite Delivery Contract (IDC SPE2DE24D0020) valued at $471.0 million and spanning from June...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a $16,500 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on July 10, 2025, for the Arthrex ACP Double Syringe System. The delivery order, which carries an ultimate completion date of July 15, 2025, represents a non-competitive award with no set-aside designation. This delivery order is issued under Arthrex's existing Indefinite Delivery Contract...
- The Defense Logistics Agency's Medical Supply Chain awarded a $11,550 fixed-price delivery order to Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies. The delivery order, issued on September 19, 2025, covers the Arthrex ACP Double Syringe System, a specialized medical device for orthopedic procedures, with an ultimate completion date of September 24, 2025. This award carries an economic price adjustment provision and was not designated as a...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $2,475 on August 6, 2025, for the Arthrex ACP Double Syringe System. This fixed-price delivery order with economic price adjustment is scheduled for completion by August 11, 2025, and represents a task order under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency's Medical Supply Chain. The contract carries no...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a $1,949.89 delivery order from the Defense Logistics Agency's Medical Supply Chain on September 15, 2025. This fixed-price contract with economic price adjustment is a non-set-aside award with an ultimate completion date of September 18, 2025. The delivery order falls under Arthrex's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (SPE2DE24D0020), valued at...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a $24,750 fixed-price delivery order with economic price adjustment for the Arthrex ACP Double Syringe System on September 8, 2025, with an ultimate completion date of September 11, 2025. The award was issued by the Defense Logistics Agency's Medical Supply Chain without a set-aside designation, reflecting Arthrex's competitive strength in the federal marketplace. The product will be...
- Arthrex Inc., a Naples, Florida-based orthopedic medical device manufacturer, received a delivery order valued at $1,321.32 from the Defense Logistics Agency's Medical Supply Chain on September 9, 2025, with completion scheduled for September 12, 2025. This fixed-price delivery order with economic price adjustment mechanism is issued under the company's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at $471.0 million and spanning from June 11, 2024,...
- Arthrex Inc., a leading orthopedic medical device manufacturer headquartered in Naples, Florida, was awarded a $3,300 delivery order for the Arthrex ACP Double Syringe System on October 27, 2025, with completion scheduled for November 10, 2025. The award carries fixed-price pricing with economic price adjustment terms and was issued without set-aside designation. This delivery order is funded through the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency...
- SPE2DE24DA017Indefinite Delivery Contract
- SPE2DE24DA017-SPE2D625F2XY2Delivery Order
Arthrex Inc., a Naples, Florida-based orthopedic medical device manufacturer, received a $1,650 fixed-price delivery order with economic price adjustment from the Defense Logistics Agency's Medical Supply Chain on June 18, 2025. The contract calls for delivery of the Arthrex ACP Double Syringe System, an orthopedic surgical device, with final completion scheduled for June 24, 2025. This delivery order was awarded without a set-aside designation, reflecting Arthrex's competitive standing in the federal healthcare marketplace. This delivery order is issued under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at approximately $471 million and running through September 2029. The parent IDC enables VA medical centers nationwide to procure Arthrex's comprehensive portfolio of orthopedic products, including surgical implants, arthroscopic instruments, and specialized surgical systems. To date, Arthrex has fulfilled over $550,000 in delivery orders under this vehicle, underscoring the company's established capability to support government healthcare requirements for military personnel and veterans requiring advanced orthopedic surgical solutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 6/18/25 |